NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,704 | -99.9% | 38,500 | 0.0% | 0.07% | -2.9% |
Q2 2023 | $1,873,410 | +91959.5% | 38,500 | +5.1% | 0.07% | -11.7% |
Q1 2023 | $2,035 | +43.0% | 36,646 | +3.4% | 0.08% | +37.5% |
Q4 2022 | $1,423 | -99.9% | 35,425 | +6.0% | 0.06% | -9.7% |
Q3 2022 | $1,464,000 | +28.1% | 33,416 | +3.6% | 0.06% | +34.8% |
Q2 2022 | $1,143,000 | -75.9% | 32,245 | -36.4% | 0.05% | -66.7% |
Q4 2021 | $4,738,000 | -32.5% | 50,731 | -19.4% | 0.14% | -36.7% |
Q3 2021 | $7,015,000 | -1.8% | 62,954 | 0.0% | 0.22% | +3.8% |
Q2 2021 | $7,147,000 | +22.2% | 62,954 | +9.3% | 0.21% | +20.0% |
Q1 2021 | $5,847,000 | -25.1% | 57,577 | -26.6% | 0.18% | -29.7% |
Q4 2020 | $7,810,000 | +34.8% | 78,481 | -2.2% | 0.25% | +17.5% |
Q3 2020 | $5,795,000 | +223.2% | 80,214 | +123.1% | 0.21% | +207.2% |
Q2 2020 | $1,793,000 | +29.0% | 35,962 | -22.7% | 0.07% | +6.2% |
Q1 2020 | $1,390,000 | -0.5% | 46,540 | +12.2% | 0.06% | +41.3% |
Q4 2019 | $1,397,000 | -32.1% | 41,471 | -33.9% | 0.05% | -33.3% |
Q3 2019 | $2,057,000 | – | 62,723 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |